dangers of compound semaglutide FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Top 5 Common Semaglutide Side

One meal ordered at a restaurant turned into 3 meals

Thyroid concerns In animal studies, GLP-1 drugs have been linked to C-cell tumors

Feel free to call us at 973-272-6220 during normal business hours

While this is a single case report and not necessarily generalizable, it underscores why thyroid monitoring during GLP-1 therapy is not optional, it is essential

STEP 5: In adults with obesity or overweight with at least one weight-related comorbidity, along with diet and exercise, Significant weight loss that lasts with Wegovy 2.4 mg 3 Co-primary end point: Mean change in body weight (%) from week 0 to week 104 3 During the trial, 13% of patients in the Wegovy arm discontinued treatment compared with 27% in the placebo arm

Heres what we know about the drugs and how long their effects last